Understanding Basilar Artery Occlusion Thrombectomy in Mild Stroke

Acute ischemic stroke resulting from vertebrobasilar occlusion represents a severe medical emergency that carries substantial morbidity and mortality. However, managing patients who present with mild neurological deficits remains an intense clinical challenge for stroke teams. Clinicians frequently question whether immediate basilar artery occlusion thrombectomy offers superior outcomes compared to best medical management alone. Although major prospective clinical trials firmly confirm mechanical thrombectomy for severe posterior circulation events, evidence remains equivocal for mild stroke presentations. Patients presenting with a National Institutes of Health Stroke Scale score of ten or lower often exhibit fluctuating symptoms and subtle neurological signs. Consequently, urgent therapeutic decisions directly influence functional independence, chronic disability, and long-term survival. Physicians must carefully evaluate whether invasive mechanical reperfusion confers advantages over intensive antithrombotic pharmacotherapy. Furthermore, endovascular intervention carries notable procedural hazards, including vascular rupture, vessel dissection, downstream micro-embolization, and symptomatic intracranial hemorrhage. Historically, observational registries reported conflicting functional outcomes in this specific patient population. Therefore, robust long-term evidence spanning beyond traditional ninety-day endpoints is critical to guide interventional teams. Establishing definitive prognostic trajectories allows vascular specialists to deliver safe, effective care for these vulnerable stroke patients while avoiding unnecessary procedural harm.

Methodology and Patient Selection in the Multicenter Registry

To evaluate long-term outcomes, researchers conducted an extensive multicenter retrospective cohort study across sixty-five comprehensive stroke centers throughout China. The registry included 1,232 consecutive patients presenting with acute basilar artery occlusion and admission stroke scores of ten or less between December 2015 and June 2022. Investigators evaluated one-year functional outcomes, comparing best medical management alone against medical therapy combined with endovascular thrombectomy. In this cohort, male participants comprised 69.5% of cases, and the overall mean age was 65 years. Additionally, researchers employed multivariable logistic regression and propensity score matching analyses to balance baseline cardiovascular risk profiles, age, and presentation characteristics. The primary outcome was favorable functional recovery, defined as a modified Rankin Scale score of zero to three at one-year follow-up. Furthermore, the research protocol stratified endovascular cases into early and late groups based on a door-to-puncture threshold of 120 minutes. This temporal distinction served as an effective clinical surrogate for primary intervention versus delayed rescue therapy after conservative treatment. Consequently, the study provides robust observational data regarding real-world stroke practice across diverse healthcare settings, clarifying outcomes over a full year.

Comparative Analysis of One-Year Functional Recovery and Mortality

The adjusted analysis revealed no statistically significant difference in one-year functional recovery between endovascular therapy and medical management alone. Specifically, patients undergoing thrombectomy achieved favorable functional independence at rates comparable to those receiving medical therapy, yielding an adjusted odds ratio of 0.96. Moreover, cumulative one-year mortality reached 16.4% in the thrombectomy cohort compared to 13.7% in the medical group. This observed difference did not attain statistical significance following comprehensive multivariable adjustment. Therefore, upfront mechanical recanalization failed to demonstrate superior functional efficacy or survival in the overall mild stroke cohort. These findings challenge the widespread assumption that endovascular intervention universally benefits patients with low neurological deficit scores. In addition, twelve-month follow-up data confirms that early clinical parity persists over extended recovery periods without delayed divergence. Although earlier registry data suggested transient ninety-day benefits, this study indicates that conservative medical stabilization offers comparable long-term protection. Furthermore, the lack of significant mortality difference suggests that withholding immediate invasive intervention does not endanger patient survival. Consequently, clinicians should not assume that invasive recanalization automatically guarantees superior recovery in mild basilar occlusions when intensive medical support is available.

Procedural Timing and the Critical Door-to-Puncture Threshold

While primary cohort analyses showed overall equivalence, predefined subgroup investigations demonstrated that procedural timing significantly altered clinical trajectories. Specifically, patients receiving late endovascular thrombectomy, defined as door-to-puncture times beyond 120 minutes, experienced markedly worse outcomes than those treated early. Delayed intervention produced a substantial reduction in favorable functional status, demonstrating an adjusted odds ratio of 0.47. Conversely, early thrombectomy completed within 120 minutes produced functional results comparable to initial medical management alone. These findings highlight the steep clinical penalty associated with diagnostic and transfer delays. When stroke teams hesitate, ischemic penumbral tissue progressively deteriorates, compounding reperfusion injury and technical risk. Delayed rescue procedures often occur after secondary neurological worsening has already caused irreversible brainstem injury. Thus, procedural delays eliminate the biological advantages of mechanical recanalization. Stroke networks must therefore streamline emergency workflows to minimize inter-facility transport intervals and in-hospital bottlenecks. If interventional specialists choose endovascular intervention, they must achieve arterial puncture within two hours to prevent clinical deterioration. Furthermore, centers should reserve delayed intervention strictly for salvage scenarios where viable tissue persists on multimodal imaging.

Clinical Synthesis and Practical Strategies for Stroke Specialists

These long-term findings provide vital practical guidance for interventionalists and acute care neurologists managing mild vertebrobasilar stroke presentations. Firstly, clinicians should avoid routine upfront mechanical recanalization as an indiscriminate standard of care for stable patients. Instead, medical teams should initiate intensive medical management with intravenous thrombolysis and dual antiplatelet therapy under close neurological surveillance. Secondly, centers must maintain rapid-response pathways to identify acute neurological deterioration immediately. If patients experience clinical worsening, interventional teams must deliver rescue thrombectomy without delay to salvage compromised tissue. Furthermore, hospitals must optimize endovascular workflows to ensure that door-to-puncture times remain strictly under 120 minutes. Specialists should also evaluate comprehensive vascular imaging, assessing basilar artery stenosis, thrombus burden, and posterior collateral circulation to personalize care. In addition, patient selection should incorporate tissue perfusion metrics rather than relying exclusively on clinical stroke scores. Finally, clinicians must engage patients and families in shared decision-making regarding procedural risks versus medical stabilization benefits. Combining vigilant medical therapy with hyper-acute rescue capabilities optimizes neurological recovery and preserves long-term quality of life for stroke survivors.

Does thrombectomy improve one-year survival in mild basilar occlusion?

Current evidence indicates that endovascular thrombectomy does not significantly improve one-year survival compared to best medical management alone. In this large multicenter cohort, one-year mortality was 16.4% with thrombectomy versus 13.7% with medical therapy. Therefore, routine invasive intervention does not confer a distinct long-term survival advantage in mild stroke presentations.

Why is door-to-puncture time critical in basilar artery occlusion?

Door-to-puncture timing directly dictates clinical outcomes in basilar occlusion. Performing thrombectomy beyond 120 minutes significantly worsens one-year functional recovery compared to earlier intervention. Delayed recanalization often occurs after irreversible brainstem ischemia develops, increasing reperfusion injury. Thus, rapid procedural execution within two hours remains essential whenever clinicians pursue endovascular recanalization.

Which patients with mild basilar occlusion may benefit from thrombectomy?

Patients experiencing acute neurological deterioration despite best medical therapy derive the greatest benefit from rescue thrombectomy. Additionally, individuals with poor collateral circulation, extensive clot burden, or fluctuating deficits may warrant early invasive intervention. Clinicians must evaluate vessel imaging and clinical stability rather than relying exclusively on initial baseline stroke scale scores.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Xu Y et al. One-Year Outcome After Endovascular Thrombectomy for Basilar Artery Occlusion With Mild Deficits. Stroke. 2025 Aug. doi: 10.1161/STROKEAHA.124.050389. PMID: 40276850.


2. Langezaal LCM, van der Hoeven EJRJ, Mont'Alverne FJA, et al. Endovascular therapy for stroke due to basilar-artery occlusion. N Engl J Med. 2021;384(20):1910-1920.


3. Jovin TG, Li C, Wu L, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion. N Engl J Med. 2022;387(15):1373-1384.